Robert Ying Jiang, Ph.D DABT, is a seasoned expert in immunology and specialty toxicology with extensive experience in the safety assessment of biopharmaceuticals. Currently serving as Senior VP at Pharmaron, Jiang leads initiatives in immunology and clinical analytical development while contributing to various scientific boards, including the Shanghai Bioinformatics Association and as an associate editor for multiple journals. Previously, Jiang held senior roles at Merck, WuXi AppTec, and Peking University, among others, after earning a Ph.D. in Biochemistry from UCLA. Their expertise spans a wide range of disciplines, including genetic toxicology, immunotherapeutics, and precision medicine.
This person is not in any teams
This person is not in any offices